Sameer Indravadan Dani

Sameer Indravadan Dani

Active Director Director DIN 00077140
DIN 00077140 First appointment Mar 2005 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Mar 2005
Shareholding value •••• Premium profile

About Sameer Indravadan Dani

Data last updated:

Sameer Indravadan Dani is a Director at Apollo Cvhf Limited (since 2016) and Director at Advanced Cardiovascular Care Private Limited (since 2005). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹38.51 Cr; the largest is Apollo Cvhf Limited at ₹34.40 Cr (FY 2025). Earlier, Sameer Indravadan Dani was a Director at Lifecare Institute Of Medical Sciences And Research Pvt. Ltd (2005–2023) and Director at Innovations In Csr Foundation (2015–2020) and 2 more.

DIN 00077140
Primary Designation Director
Industry Healthcare
First Appointment 17 Mar 2005
Oldest Company Age 21 yrs
Largest company Apollo Cvhf Limited · ₹34.40 Cr (FY 2025)
Combined revenue ₹38.51 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apollo Cvhf Limited U74140GJ2016PLC086449
Director29 Aug 20162016₹34.40 Cr (FY 2025)Active
Director17 Mar 20052005₹4.11 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20052005₹21.64 Cr (FY 2023)Active
Innovations In Csr Foundation U85190DL2015NPL380932
Director15 Apr 20152015₹2 Lakh (FY 2024)Active
Managing Director09 Jun 20051995₹4.51 Cr (FY 2025)Active
Director01 Aug 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apollo Cvhf Limited
Advanced Cardiovascular Care Private Limited
Crystal Cardiovascular Health And Fitness Private Limited
Lifecare Institute Of Medical Sciences And Research Pvt. Ltd
Premium access

Shareholding and investment profile for Sameer Indravadan Dani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Indravadan Dani

Sameer Indravadan Dani currently holds 2 directorships: Apollo Cvhf Limited (Director, since 29 Aug 2016, revenue ₹34.40 Cr (FY 2025)); Advanced Cardiovascular Care Private Limited (Director, since 17 Mar 2005, revenue ₹4.11 Cr (FY 2025)).

Sameer Indravadan Dani was first appointed on 17 Mar 2005 as Director at Advanced Cardiovascular Care Private Limited. The most recent appointment on record is 29 Aug 2016 at Apollo Cvhf Limited.

The 2 current companies of Sameer Indravadan Dani that report revenue have a combined latest revenue of ₹38.51 Cr: Apollo Cvhf Limited ₹34.40 Cr (FY 2025); Advanced Cardiovascular Care Private Limited ₹4.11 Cr (FY 2025).

Sameer Indravadan Dani held 4 earlier board appointments: Lifecare Institute Of Medical Sciences And Research Pvt. Ltd (Director, 09 Jun 2005 to 06 Jul 2023); Innovations In Csr Foundation (Director, 15 Apr 2015 to 02 Aug 2020); Lifecare Emergency Centre Private Limited (Managing Director, 09 Jun 2005 to 01 Apr 2008); Crystal Cardiovascular Health And Fitness Private Limited (Director, from 01 Aug 2012).

The current boards of Sameer Indravadan Dani's companies include Akhileswaran Krishnan (Apollo Cvhf Limited), Amitabha Banerjee (Apollo Cvhf Limited), Preetha Reddy (Apollo Cvhf Limited), Rajiv Indravadan Modi (Apollo Cvhf Limited), Sudhir Kumar Sahu (Apollo Cvhf Limited), Vaibhav Nagar (Apollo Cvhf Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available